Translational vision science & technology. 2025 Apr 1;14(4):11. doi: 10.1167/tvst.14.4.11 Q22.62024

Comments on Xie et al.'s Study on Artificial Intelligence-Assisted Perfusion Density as Biomarker for Screening Diabetic Nephropathy

谢等关于人工智能辅助灌注密度作为筛查糖尿病肾病生物标志物的研究评论 翻译改进

作者单位 +展开

DOI: 10.1167/tvst.14.4.11 PMID: 40197733

摘要 中英对照阅读

Copyright © Translational vision science & technology. 中文内容为AI机器翻译，仅供参考！

相关内容

• Artificial Intelligence-Assisted Perfusion Density as Biomarker for Screening Diabetic Nephropathy

  人工智能辅助灌注密度筛查糖尿病肾病的标志物

  Xiao Xie et al.

  Translational vision science & technology. 2024 Oct 1;13(10):19.

• Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy

  生长阻滞特异性蛋白6(Gas6)作为非侵入性生物标志物在糖尿病肾病早期检测中的应用

  Wenni Li et al.

  Clinical and experimental hypertension (New York, N.Y. : 1993). 2017;39(4):382-387.

• Elevated urinary level of vitamin D-binding protein as a novel biomarker for diabetic nephropathy

  维生素D结合蛋白作为糖尿病肾病新型生物标志物的尿检水平升高

  Xiao-Qin Tian et al.

  Experimental and therapeutic medicine. 2014 Feb;7(2):411-416.

• Lumican as a potential biomarker for diabetic nephropathy

  糖连蛋白可作为糖尿病肾病生物标志物的潜在候选分子

  Yuejia Tao et al.

  Renal failure. 2025 Dec;47(1):2480245.

• Prediction of diabetic nephropathy: The need for a sweet biomarker

  糖尿病肾病的预测：对“甜”生物标志物的需求

  Ramin Tolouian

  Journal of nephropathology. 2013 Jan;2(1):4-5.

• Smad1 as a biomarker for diabetic nephropathy

  Smad1作为糖尿病肾病的生物标志物

  Hideki Kato et al.

  Diabetes. 2008 Jun;57(6):1459-60.

• Urinary angiotensinogen as a potential biomarker of diabetic nephropathy

  尿激肽原酶作为糖尿病肾病潜在生物标志物的可能性

  Bancha Satirapoj

  Clinical kidney journal. 2014 Aug;7(4):354-60.

• Urinary Smad1 is a new biomarker for diagnosis and evaluating the severity of diabetic nephropathy

  尿液Smad1是诊断糖尿病肾病及其严重程度的新生物标志物

  Qiao Li et al.

  Endocrine. 2014 May;46(1):83-9.